Cargando…

Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia

Men with early-onset androgenetic alopecia are characterized by hormonal profiles similar to those observed in women with polycystic ovary syndrome. The purpose of this research was to investigate levels of cardiometabolic risk factors in 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA)-treated men w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krysiak, Robert, Basiak, Marcin, Okopień, Bogusław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151490/ https://www.ncbi.nlm.nih.gov/pubmed/34064815 http://dx.doi.org/10.3390/molecules26102844

Ejemplares similares

Impaired metabolic effects of metformin in men with early-onset androgenic alopecia
por: Krysiak, Robert, et al.
Publicado: (2021)

The impact of rosuvastatin on hypothalamic–pituitary–testicular axis activity in metformin-treated and metformin-naïve men with low testosterone levels: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2021)

The impact of exogenous vitamin D on thyroid autoimmunity in euthyroid men with autoimmune thyroiditis and early-onset androgenic alopecia
por: Krysiak, Robert, et al.
Publicado: (2021)

Vitamin D Status Determines Cardiometabolic Effects of Cabergoline in Women with Elevated Prolactin Levels: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

The impact of hypotestosteronemia on cardiometabolic effects of atorvastatin in men with hypercholesterolemia: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2021)

Plasma Concentrations of New Biochemical Markers of Atherosclerosis in Patients with Dyslipidemia—A Pilot Study
por: Kosowski, Michał, et al.
Publicado: (2022)

Rosuvastatin Potentiates Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

Myo-Inositol Potentiates the Inhibitory Effect of Metformin on Prolactin Levels
por: Krysiak, Robert, et al.
Publicado: (2023)

Impaired Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women with Autoimmune Thyroiditis: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

Pleiotropic Action of Short-Term Metformin and Fenofibrate Treatment, Combined With Lifestyle Intervention, in Type 2 Diabetic Patients With Mixed Dyslipidemia
por: Pruski, Maciej, et al.
Publicado: (2009)

Cardiometabolic profile of young women with hypoprolactinemia
por: Krysiak, Robert, et al.
Publicado: (2022)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Impact of PCSK9 Inhibition on Proinflammatory Cytokines and Matrix Metalloproteinases Release in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Basiak, Marcin, et al.
Publicado: (2022)

The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2020)

Correction to: The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2021)

Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2022)

The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods
por: Basiak, Marcin, et al.
Publicado: (2023)

Cardiometabolic Effects of Cabergoline and Combined Oral Contraceptive Pills in Young Women with Hyperprolactinemia: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

Effect of PCSK9 Inhibitors on Hemostasis in Patients with Isolated Hypercholesterolemia
por: Basiak, Marcin, et al.
Publicado: (2022)

Plasma Concentrations of Cytokines in Patients with Combined Hyperlipidemia and Atherosclerotic Plaque before Treatment Initiation—A Pilot Study
por: Basiak, Marcin, et al.
Publicado: (2022)

Does Therapy with Glucagon-like Peptide 1 Receptor Agonists Have an Effect on Biochemical Markers of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)? Pleiotropic Metabolic Effect of Novel Antidiabetic Drugs in Patients with Diabetes—Interventional Study
por: Hachuła, Marcin, et al.
Publicado: (2023)

The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2014)

Fungal infection mimicking COVID-19 infection – A case report
por: Niemiec, Aleksandra, et al.
Publicado: (2022)

The Impact of Various Methods of Obesity Treatment on the Quality of Life and Mental Health—A Narrative Review
por: Hachuła, Marcin, et al.
Publicado: (2023)

Efficacy and safety of rosuvastatin in the management of dyslipidemia
por: Rubba, Paolo, et al.
Publicado: (2009)

Coexistence of primary aldosteronism and Hashimoto’s thyroiditis
por: Krysiak, Robert, et al.
Publicado: (2011)

Colchicine — From rheumatology to the new kid on the block: Coronary syndromes and COVID-19
por: Surma, Stanisław, et al.
Publicado: (2023)

Factors Influencing Depression in Korean Men with Androgenic Alopecia
por: KIM, Jung-Won
Publicado: (2021)

Recurrent pancreatitis induced by hyperparathyroidism in pregnancy
por: Krysiak, Robert, et al.
Publicado: (2010)

Pleiotropic Effects of PCSK-9 Inhibitors
por: Basiak, Marcin, et al.
Publicado: (2021)

Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia
por: Li, Zhiming, et al.
Publicado: (2015)

Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights
por: Chilbert, Maya R, et al.
Publicado: (2022)

The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia
por: Krysiak, Robert, et al.
Publicado: (2011)

Endocrine Symptoms as the Initial Manifestation of Wilson’s Disease
por: Krysiak, Robert, et al.
Publicado: (2012)

The role of adipokines in connective tissue diseases
por: Krysiak, Robert, et al.
Publicado: (2012)

The Effect of Metformin on Plasma Prolactin Levels in Young Women with Autoimmune Thyroiditis
por: Krysiak, Robert, et al.
Publicado: (2023)

Vitamin D Status Determines the Impact of Metformin on Gonadotropin Levels in Postmenopausal Women
por: Krysiak, Robert, et al.
Publicado: (2023)

Sexual Function and Depressive Symptoms in Young Women with Euthyroid Hashimoto’s Thyroiditis Receiving Vitamin D, Selenomethionine and Myo-Inositol: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
por: Krysiak, Robert, et al.
Publicado: (2023)

Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro
por: Bułdak, Łukasz, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lgohsu8oveaqj5qonc29237oli